Tamiflu® (oseltamivir phosphate) is an antiviral medicine for treatment of flu in people 2 weeks of age and older and for prevention of flu in people 1 year of age and older. See full safety for more information.
Employees: 11-50
Mentions in press and media 5
| Date | Title | Description |
| 16.09.2024 | Hyundai Bioscience Unveils XAFTY®: A New Hope in the Fight Against Viruses | In a world still reeling from the effects of COVID-19, the announcement of a new antiviral drug could be a game-changer. Hyundai Bioscience has introduced XAFTY®, a broad-spectrum antiviral that promises to tackle multiple viral threats, in... |
| 11.09.2024 | Hyundai Bioscience announces XAFTY®, a groundbreaking broad-spectrum antiviral capable of treating COVID-19, mpox, and dengue | Hyundai Bioscience presents development updates of its broad-spectrum antiviral at the "Disease Prevention and Control Summit 2024" held in Philadelphia, USA. SEOUL, South Korea, Sept. 11, 2024 /PRNewswire/ -- Dr. Heung-Jeong Woo,... |
| 11.09.2024 | Hyundai Bioscience announces XAFTY®, a groundbreaking broad-spectrum antiviral capable of treating COVID-19, mpox, and dengue | Hyundai Bioscience presents development updates of its broad-spectrum antiviral at the "Disease Prevention and Control Summit 2024" held in Philadelphia, USA. SEOUL, South Korea, Sept. 11, 2024 /PRNewswire/ -- Dr. Heung-Jeong Woo,... |
| 12.08.2013 | Beware the Blob: Biotech building tiny death traps that bind to viruses at cellular level | FluCide: Anti-influenza drug candidate shown to be 15 times more effective than an extended treatment with antiviral drug Tamiflu (Roche). HIVCide: Anti-HIV drug candidate demonstrating effectiveness equal to a three-drug cocktail (HAART). ... |
| - | Beware the Blob: Biotech building tiny death traps that bind to viruses at cellular level | NanoViricides Inc., is working on a platform technology that uses “nanoviricides” to trap and destroy pathogenic viruses. These nanoviricides are nano-sized flexible structures comprised of polymeric lipids that have the virus-binding ligan... |